Skip to main content
Veterinary Medicines

RABISIN, ενέσιμο εναιώρημα

Authorised
  • Rabies virus, strain G52, Inactivated

Product identification

Medicine name:
RABISIN, ενέσιμο εναιώρημα
Active substance:
  • Rabies virus, strain G52, Inactivated
Target species:
  • Horse
  • Cattle
  • Sheep
  • Dog
  • Cat
  • Ferret
Route of administration:
  • Intramuscular use
  • Subcutaneous use

Product details

Active substance and strength:
  • Rabies virus, strain G52, Inactivated
    2.09
    log 10 optical density 50
    /
    1.00
    dose
Pharmaceutical form:
  • Suspension for injection
Withdrawal period by route of administration:
  • Intramuscular use
    • Horse
      • Not applicable
        no withdrawal period
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
    • Ferret
      • Not applicable
        no withdrawal period
  • Subcutaneous use
    • Cattle
      • Not applicable
        no withdrawal period
    • Sheep
      • Not applicable
        no withdrawal period
    • Dog
      • Not applicable
        no withdrawal period
    • Cat
      • Not applicable
        no withdrawal period
    • Ferret
      • Not applicable
        no withdrawal period
Anatomical therapeutic chemical veterinary (ATCvet) codes:
  • QI07AA02
Authorisation status:
  • Valid
Authorised in:
  • Greece
Available in:
  • Greece
Package description:

Additional information

Entitlement type:
  • Marketing Authorisation
Marketing authorisation holder:
  • Boehringer Ingelheim Animal Health France
Marketing authorisation date:
Manufacturing sites for batch release:
  • Boehringer Ingelheim Animal Health France
Responsible authority:
  • National Organization For Medicines
Authorisation number:
  • 57429/02-06-2020/K-0013001
Date of authorisation status change:
How useful was this page?:
No votes yet
"Please do not include any personal data, such as your name or contact details. If you do, you consent to the processing of that data in accordance with EMA’s Privacy Statement concerning requests for information or access to documents. If you would like a reply from EMA, please Send a question to EMA instead."